However, their success depends on personalized care, where patients and healthcare providers work together to choose the best treatment
Decision matrix Safety considerations researchers should know Both compounds are newer than established GLP-1 agonists , which means their long-term safety profiles are still being characterized
[12] [13] This delayed gastric emptying contributes to the appetite-suppressing effect of the drug, but it may also mean that stomach contents, including acid, remain in the stomach for longer
Manufacturer copay programs can reduce costs even more, with some patients paying only $25 to $50 per month if they qualify
The safety and efficacy of GLP-1 receptor agonists in pregnancy: A systematic review
The vast majority of people taking semaglutide do not develop allodynia